PMG Research   Report issue

For profit Phase 2 Phase 3
Founded: Winston-Salem NC United States (1979)
Status: Acquired by ICON (2015)

Organization Overview

First Clinical Trial
2006
NCT00350298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

All-Trials Clinical Research, LLC, Winston-Salem, NC | Piedmont Medical Research | Piedmont Medical Research Associates | PMG Cary Medical Research | PMG Research | PMG Research of Charlotte | PMG Research of Charlotte, LLC | PMG Research of Knoxville | PMG Research of Raleigh | PMG Research of Raleigh, LLC | PMG Research of Salisbury | PMG Research of Winston Salem, LLC | PMG Research of Winston-Salem, LLC | Wilmington Medical Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Clostridium Infections (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Erythema (Phase 3)

Hot Flashes (Phase 2)

Hypertriglyceridemia (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 12